(Reuters) - The U.S. Food and Drug Administration on Tuesday rejected Prevention Bio Inc.'s approval of the experimental diabetes drug teplizumab, citing insufficient data,...
InsightSLICE latest study Tittles Essential Oils Marketsheds light on the various segments of the essential oils market. The report should guide the reader...